Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
107.00
+3.00 (2.88%)
At close: Feb 10, 2026
-12.51% (1Y)
| Market Cap | 24.72B -17.9% |
| Revenue (ttm) | 11.58B +23.1% |
| Net Income | 570.05M -13.9% |
| EPS | 2.47 -13.9% |
| Shares Out | 231.00M |
| PE Ratio | 43.36 |
| Forward PE | n/a |
| Dividend | 2.10 (1.96%) |
| Ex-Dividend Date | Nov 17, 2025 |
| Volume | 338,092 |
| Average Volume | 277,282 |
| Open | 105.00 |
| Previous Close | 104.00 |
| Day's Range | 105.00 - 107.50 |
| 52-Week Range | 92.40 - 147.50 |
| Beta | -0.63 |
| RSI | 56.43 |
| Earnings Date | Jan 28, 2026 |